Terry Vuong, DO
575 Underhill Blvd Suite 190
Syosset, NY 11791
Dr. Terry Vuong is board certified in Family Medicine and Obesity Medicine. He completed his residency at Hackensack University Medical Center at Palisades in North Bergen, NJ. He earned his Doctor of Osteopathic Medicine from New York Institute of Technology College of Osteopathic Medicine in Old Westbury, New York, and holds a Master of Science in Physiology from Georgetown University in Washington, DC.
Dr. Vuong believes lifestyle interventions are the primary modality to treating and preventing illnesses. Dr. Vuong has a professional interest in preventive medicine, bariatric medicine, primary care medicine, addiction medicine, and patient education.
- Undergraduate & Graduate
- Georgetown University, Master of Science, Physiology
- Stony Brook University, Bachelor of Science, Biochemistry
- Medical Education
- aNew York Institute of Technology College of Osteopathic Medicine, Doctor of Osteopathic Medicine
- Hackensack University Medical Center at Palisades Traditional Rotating Internship
- Hackensack University Medical Center at Palisades Family Medicine Residency
- Hackensack Meridian Health Palisades Medical Center
- Board Certifications
- American Board of Family Medicine
- American Board of Obesity Medicine
- Vuong, T., Sirajuddin, S., Baker, I. “What is the impact of the Flu vaccine on the annual Household Income.” Manuscript accepted. Family Physicians Inquires Network.
- Williams, A., Auyeung, G., Lamprou, S., Vuong, T., Baker, I. “What is the risk of DVT/PE in patients diagnosed with superficial vein thrombosis.” Manuscript accepted. Family Physicians Inquires Network.
- Vuong, T., Atoot, A. “Shared Decision With Usage Of Aspirin For Primary Prevention” Riverside Newsletter 2018
- Colizza W, Kim S, Patel H., Vuong, T. 2012. Promising Approaches to Curing Type 1 Diabetes. “Current Opinions in Sexual Development and Reproduction”. An academic journal of the School of Medicine, Georgetown University Medical Center, Special Master’s Program in Physiology, Volume 4.
- Barbieri CE, Baca SC, Lawrence MS, Demichelis F, Blattner M, Theurillat JP, White TA, Stojanov P, Allen EV, Stransky N, Nickerson E, Chae SS, Boysen G, Auclair D, Onofrio R, Park K, Kitabayashi N, MacDonald TY, Sheikh K, Vuong T, Guiducci C, Cibulskis K, Sivachenko A, Scott L., Carter SL, Saksena G, Voet D, Hussain WM, Ramos AH, Winckler W, Redman MC, Ardlie K, Tewari AK, Mosquera JM, Rupp N, Wild PJ, Moch H, Morissey C, Nelson PS, Kantoff PW, Gabriel SB, Golub TR, Meyerson M, Lander ES, Getz G, Rubin MA and Garraway LA. “Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer” Nature Genetics 05.20 (2012): 44(6):685 - 9.
- Rickman D, Ying-bei Chen Y, Banerjee S, Pan Y, Yu J, Vuong T, Perner S, LaFargue CJ, Mertz KD, Setlur SR, Sircar K, Chinnaiyan AM, Bismar TA, Rubin MA and Demichelis F. “ERG cooperates with androgen receptor in regulating trefoil factor 3 in prostate cancer disease progression.” Neoplasia 12.12 (2010): 1031 - 1040.